Kelly Shi
Stock Analyst at Jefferies
(3.26)
# 996
Out of 5,149 analysts
34
Total ratings
48.48%
Success rate
17.78%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Maintains: Buy | $8 → $9 | $10.00 | -10.00% | 2 | Dec 12, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $73 → $122 | $86.35 | +41.29% | 2 | Dec 9, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $64.39 | +19.58% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $147.00 | +0.68% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $37.24 | -24.81% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $15.11 | +191.20% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $5.68 | +164.08% | 1 | Apr 10, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $8.30 | +526.51% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $5.52 | +153.62% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $26.20 | -27.48% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $174 → $196 | $239.22 | -18.07% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $5.47 | +283.91% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $21.40 | +72.90% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $2.21 | +171.49% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $98.07 | -17.41% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.94 | +46.20% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $3.25 | +1,007.69% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $17.69 | -9.55% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $17.96 | +11.36% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $432 | $7.02 | +6,053.85% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $13.49 | +285.61% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.48 | +988.71% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $2.97 | +1,011.11% | 1 | Mar 8, 2021 |
ImmunityBio
Dec 12, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $10.00
Upside: -10.00%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $73 → $122
Current: $86.35
Upside: +41.29%
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $64.39
Upside: +19.58%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $147.00
Upside: +0.68%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $37.24
Upside: -24.81%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $15.11
Upside: +191.20%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $5.68
Upside: +164.08%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $8.30
Upside: +526.51%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $5.52
Upside: +153.62%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $26.20
Upside: -27.48%
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $239.22
Upside: -18.07%
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $5.47
Upside: +283.91%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $21.40
Upside: +72.90%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.21
Upside: +171.49%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $98.07
Upside: -17.41%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $23.94
Upside: +46.20%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $3.25
Upside: +1,007.69%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $17.69
Upside: -9.55%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $17.96
Upside: +11.36%
Mar 4, 2022
Initiates: Buy
Price Target: $432
Current: $7.02
Upside: +6,053.85%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $13.49
Upside: +285.61%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.48
Upside: +988.71%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $2.97
Upside: +1,011.11%